GV0
golvatinib
Created: | 2016-02-21 |
Last modified: | 2016-11-09 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 83 |
Chiral Atom Count | 0 |
Bond Count | 88 |
Aromatic Bond Count | 18 |
Chemical Component Summary | |
---|---|
Name | golvatinib |
Systematic Name (OpenEye OEToolkits) | ~{N}1'-[2-fluoranyl-4-[2-[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonylamino]pyridin-4-yl]oxy-phenyl]-~{N}1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
Formula | C33 H37 F2 N7 O4 |
Molecular Weight | 633.688 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | C1CN(C)CCN1C2CCN(CC2)C(Nc3nccc(c3)Oc4ccc(c(c4)F)NC(C5(CC5)C(Nc6ccc(cc6)F)=O)=O)=O |
SMILES | CACTVS | 3.385 | CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(Oc4ccc(NC(=O)C5(CC5)C(=O)Nc6ccc(F)cc6)c(F)c4)ccn3 |
SMILES | OpenEye OEToolkits | 2.0.4 | CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(ccn3)Oc4ccc(c(c4)F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F |
Canonical SMILES | CACTVS | 3.385 | CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(Oc4ccc(NC(=O)C5(CC5)C(=O)Nc6ccc(F)cc6)c(F)c4)ccn3 |
Canonical SMILES | OpenEye OEToolkits | 2.0.4 | CN1CCN(CC1)C2CCN(CC2)C(=O)Nc3cc(ccn3)Oc4ccc(c(c4)F)NC(=O)C5(CC5)C(=O)Nc6ccc(cc6)F |
InChI | InChI | 1.03 | InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45) |
InChIKey | InChI | 1.03 | UQRCJCNVNUFYDX-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB11977 |
---|---|
Name | Golvatinib |
Groups | investigational |
Description | Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck. |
Synonyms |
|
Categories |
|
CAS number | 928037-13-2 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL3039525 |
PubChem | 16118392 |
ChEMBL | CHEMBL3039525 |